LOAN RECEIVABLE	6 Months Ended
Jun. 30, 2025
LOAN RECEIVABLE
LOAN RECEIVABLE	NOTE 6 – LOAN RECEIVABLE On October 30, 2021, the Company entered into an agreement for a ten-year loan with Medihelm SA to memorialize €4,284,521 ($4,849,221) in prepayments the Company had made. The prepayments to Medihelm SA had been made in accordance with the parallel export business, through which Medihelm supplied and would supply SkyPharm SA with branded pharmaceuticals. This business is no longer in place for the Company and thus the Company entered into this agreement with Medihelm SA in order for the outstanding amount to be settled. Interest is calculated at a rate of 5.5% per annum on a 360-day basis. Under the terms of the agreement, the Company is to receive 120 equal payments over the term of the loan. During the three and six months ended June 30, 2025, the Company accrued interest income of €46,198 ($50,554) and €89,377 ($97,804) in connection with the note receivable governed by this agreement. During the six-month period ended June 30, 2025 the Company received €333,241 ($392,225) in principal payments in connection with this Note. No interest payments were received during the period. The Note is considered fully recoverable as of June 30, 2025.

LOAN RECEIVABLE

6 Months Ended

Jun. 30, 2025

NOTE 6 – LOAN RECEIVABLE

On October 30, 2021, the Company entered into an agreement for a ten-year loan with Medihelm SA to memorialize €4,284,521 ($4,849,221) in prepayments the Company had made. The prepayments to Medihelm SA had been made in accordance with the parallel export business, through which Medihelm supplied and would supply SkyPharm SA with branded pharmaceuticals. This business is no longer in place for the Company and thus the Company entered into this agreement with Medihelm SA in order for the outstanding amount to be settled. Interest is calculated at a rate of 5.5% per annum on a 360-day basis. Under the terms of the agreement, the Company is to receive 120 equal payments over the term of the loan. During the three and six months ended June 30, 2025, the Company accrued interest income of €46,198 ($50,554) and €89,377 ($97,804) in connection with the note receivable governed by this agreement. During the six-month period ended June 30, 2025 the Company received €333,241 ($392,225) in principal payments in connection with this Note. No interest payments were received during the period. The Note is considered fully recoverable as of June 30, 2025.